| Website | paradigm-spine.de |
| Category | BioTech |
| Phone | 1-646-3491173 |
| Employees | |
| Description | medical device company |
| TOTAL | $6.5M |
| VENTURE FUNDING TOTAL | $6.5M |
| Series E, 9/09 Trevi Health Ventures Praefinium Group | $6.5M |
Paradigm Spine, LLC (Paradigm Spine) is a privately-held medical device company, engaged in the development of spinal implants for the spine and orthopedic markets. It develops non fusion spinal implants, motion preserving products and tissue sparing products. Paradigm Spine’s product Coflex, an interspinous implant used in the treatment of facet arthosis and decompressive procedures. Its products are used for spinal stabilization, rebalances spinal segment and restores natural anatomical function. The company is headquartered in New York, the US. The company also focused on the development of DSS system, a minimally-invasive pedicle-screw based system, which received a European CE Mark in April 2007 and FDA market clearance in January 2008.
